Results
1
1 companies
argenx
Market Cap: €44.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€686.40
7D
-2.6%
1Y
31.2%
